Limited specificity of serologic tests for SARS-CoV-2 antibody detection, Benin, Western Africa

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Deutsche Gesellschaft fuer Internationale Zusammenarbeit (GIZ) GmbH.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the ethics committee of the Ministry of Health (Arrete 2020 No. 030/MS/DC/SGM/DNSP/CJ/SA/027SGG2020) and followed the Declaration of Helsinki. Written consent was obtained from all the patients participating in the study. Anonymized datasets were used, and all analysis of personally identifiable data took place only in the LFHB.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes